Muge Coskun Yildirim

Mrs. Muge Coskun Yildirim

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2026 in Journal of Human Lactation
Verified
Journal Article
Closed access
SDSinem Güven Dinmez
Sinem Güven Dinmez
ZGZehra Gölbaşı
Zehra Gölbaşı
KEKafiye Eroğlu
Kafiye Eroğlu
MYMuge Coskun Yildirim
Muge Coskun Yildirim
Introduction: One of the obstacles to breastfeeding is the false beliefs in society about human milk and breastfeeding. Research Aim: The aim of this study is to develop the “Human Milk and Breastfeeding Myths Scale” and test its validity and reliability. Methods: This methodological study included 326 participants (individuals in the last trimester of pregnancy and breastfeeding individuals with infants aged 0–2 years) recruited from two public hospitals in Istanbul, Turkey. Data were collected using the Descriptive Participant Data Form and the Human Milk and Breastfeeding Myths Scale. Reliability analyses included internal consistency and a test–retest assessment conducted at a 2-week interval ( n = 34). The study was reported in accordance with the STROBE guidelines, and a pilot test was conducted with 10 participants. Results: The draft scale initially consisted of 32 items and was evaluated by experts. Following exploratory factor analysis, eight items with low factor loadings were removed, and content validity was supported using the Lawshe technique. The final 24-item scale demonstrated a structure with two factors with eigenvalues greater than 1 and a dominant first factor, with good internal consistency (α = .86). Conclusion: The Human Milk and Breastfeeding Myths Scale demonstrated acceptable validity evidence and good reliability, and may be used to assess beliefs related to breastfeeding myths.

15 September 2026 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Nida Aslan KarakelleNida Aslan Karakelle
Nida Aslan Karakelle
SGSafiye Göçer
Safiye Göçer
EEEsra Eruyar
Esra Eruyar
YAYasemin Atici
Yasemin Atici
MYMuge Coskun Yildirim
Muge Coskun Yildirim
Introduction: Alzheimer’s disease dementia (AD dementia) is a progressive neurodegenerative disorder associated with cognitive decline. Oxidative stress and inflammation may contribute to its pathophysiology, with clusterin (CLU) and sestrin-2 (SESN2) emerging as potential biomarkers. This study evaluated oxidative stress markers, inflammatory indices, and serum CLU and SESN2 levels in patients with AD dementia. Methods: A total of 48 patients with AD dementia and 39 healthy controls in a broadly comparable age range were enrolled from a neurology outpatient clinic. AD dementia was diagnosed according to internationally accepted clinical criteria. Cognitive function was assessed using Mini-Mental State Examination (MMSE) scores obtained at diagnosis. Serum malondialdehyde (MDA), glutathione (GSH), CLU, and SESN2 were measured, with MDA and GSH analyzed spectrophotometrically and CLU and SESN2 concentrations determined using the enzyme-linked immunosorbent assay (ELISA). Inflammatory indices were calculated from routine hematological and biochemical parameters. Results: A multivariable logistic regression model including age, MDA, and GSH showed excellent discriminatory performance for distinguishing patients with AD dementia from healthy controls. Patients with AD dementia had significantly lower SESN2 levels (p < 0.001) and higher CLU levels (p < 0.001) than controls. No significant associations were observed between inflammatory indices and the investigated clinical or biochemical variables in the AD dementia group (p > 0.05). Conclusions: Oxidative stress and altered SESN2 and CLU levels may be associated with AD dementia, whereas the inflammatory indices showed limited utility. Larger prospective studies are needed to validate these findings and clarify their clinical significance.